<DOC>
	<DOCNO>NCT01020825</DOCNO>
	<brief_summary>The purpose extension investigate confirm long-term ( 6 month ) safety efficacy precede FATT-1 trial [ ClinicalTrials.gov identifier : NTC00475410 ] , study patient perianal fistula treat received adipose-derived adult stem cell ( ASC ) and/or fibrin glue .</brief_summary>
	<brief_title>Long-term Safety Efficacy Adipose-derived Stem Cells Treat Complex Perianal Fistulas Patients Participating FATT-1 Randomized Controlled Trial</brief_title>
	<detailed_description>Complex perianal fistula source great distress suffers . Treatment option limit surgery often associate incontinence recurrence . The biological property stem cell derive adult tissue make candidate treatment pathology require tissue regeneration diseases heal process alter . This study aim evaluate safety efficacy patient participate within precede multicenter , placebo-controlled , phase 3 study [ ClinicalTrials.gov identifier : NTC00475410 ] . The present extension aim collect safety efficacy data 12 month initial administration . Fistula closure define absence suppuration external orifice complete re-epithelization external orifice absence collection &gt; 2cm directly relate fistula tract treat , measure MRI .</detailed_description>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Rectal Fistula</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>At least 1 dose treatment assign FATT1 trial Informed consent Other experimental drug Cx401 followup period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Complex perianal fistula</keyword>
	<keyword>Adipose-derived adult stem cell</keyword>
	<keyword>Fibrin glue</keyword>
</DOC>